348 related articles for article (PubMed ID: 28355926)
1. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926
[TBL] [Abstract][Full Text] [Related]
2. Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
Wesevich A; Hosseinipour MC; Golin CE; McGrath N; Tsidya M; Chimndozi L; Bhushan N; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2020 Feb; 32(2):170-174. PubMed ID: 31238717
[TBL] [Abstract][Full Text] [Related]
3. Recruiting male partners for couple HIV testing and counselling in Malawi's option B+ programme: an unblinded randomised controlled trial.
Rosenberg NE; Mtande TK; Saidi F; Stanley C; Jere E; Paile L; Kumwenda K; Mofolo I; Ng'ambi W; Miller WC; Hoffman I; Hosseinipour M
Lancet HIV; 2015 Nov; 2(11):e483-91. PubMed ID: 26520928
[TBL] [Abstract][Full Text] [Related]
4. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
[TBL] [Abstract][Full Text] [Related]
5. "We have heard it together": a qualitative analysis of couple HIV testing and counselling recruitment in Malawi's Option B+ programme.
Rosenberg NE; Gross R; Mtande T; Maman S; Golin CE; Saidi F; Manthalu O; Hoffman I; Hosseinipour MC; Miller WC
Afr J AIDS Res; 2017 Sep; 16(3):215-223. PubMed ID: 28978289
[TBL] [Abstract][Full Text] [Related]
6. Impact of inter-partner HIV disclosure patterns in Malawi's PMTCT program: A mixed-method study.
van Lettow M; Cataldo F; Landes M; Kasende F; Nkhoma P; van Oosterhout JJ; Kim E; Schouten E; Nkhoma E; Nyirenda R; Tippett Barr BA
PLoS One; 2019; 14(7):e0219967. PubMed ID: 31348782
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with retention in Option B+ in Malawi: a case control study.
Hoffman RM; Phiri K; Parent J; Grotts J; Elashoff D; Kawale P; Yeatman S; Currier JS; Schooley A
J Int AIDS Soc; 2017 Apr; 20(1):21464. PubMed ID: 28453243
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
9. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
[TBL] [Abstract][Full Text] [Related]
10. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
11. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
[TBL] [Abstract][Full Text] [Related]
12. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
[TBL] [Abstract][Full Text] [Related]
13. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi.
Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Harrington BJ; DiPrete B; Wallie S; Jumbe A; Limarzi L; Hosseinipour MC
PLoS One; 2018; 13(12):e0209052. PubMed ID: 30543685
[TBL] [Abstract][Full Text] [Related]
15. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
[TBL] [Abstract][Full Text] [Related]
16. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
[TBL] [Abstract][Full Text] [Related]
17. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
[TBL] [Abstract][Full Text] [Related]
18. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
[TBL] [Abstract][Full Text] [Related]
19. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi.
Chan AK; Kanike E; Bedell R; Mayuni I; Manyera R; Mlotha W; Harries AD; van Oosterhout JJ; van Lettow M
J Int AIDS Soc; 2016; 19(1):20672. PubMed ID: 26976377
[TBL] [Abstract][Full Text] [Related]
20. Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV.
Omonaiye O; Kusljic S; Nicholson P; Mohebbi M; Manias E
Int J Infect Dis; 2019 Apr; 81():225-230. PubMed ID: 30790723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
